Clinical trial
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and…
NCT00405548 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00405548 |
|---|---|
| Title | Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function. |
| Official title | To Define in Human Preclinical Diastolic Dysfunction (PDD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institutes of Health (NIH) NIH Scios, Inc. Industry National Heart, Lung, and Blood Institute (NHLBI) National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Left Ventricular Diastolic Dysfunction |
| Intervention type | Drug |
| Interventions | BNP (nesiritide), Placebo |
| Enrollment | 41 |
| Start date | Mar 1, 2008 |
| Primary completion | Apr 1, 2011 |
| Completion | Aug 1, 2012 |
| First posted | Nov 30, 2006 |
| Last update posted | Jul 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: